CRISPR Systems: Nature's Toolkit for Genome Editing | Jennifer Doudna Lecture

Added:

The Ethical and Biological Risks of Germline Modification and Off-Target Effects

While CRISPR-Cas9 is celebrated for its revolutionary precision, a significant counter-perspective emphasizes its unresolved biological risks and ethical dilemmas. Critics and cautious scientists highlight the persistence of 'off-target effects,' where CRISPR makes unintended cuts in the genome, potentially causing cancerous mutations or genomic instability. Furthermore, the application of CRISPR to human germline editing (making heritable changes) faces severe ethical opposition. Opponents argue that germline modification risks introducing irreversible genetic errors into the human gene pool, lacks the consent of future generations, and could exacerbate social inequalities by paving the way for 'designer babies.' This critical viewpoint argues for strict international moratoria on germline editing and advocates for alternative, safer technologies—such as base editing or prime editing—which do not rely on making double-stranded DNA breaks, thereby minimizing the risks associated with traditional CRISPR-Cas9 tools.

The structure and function of DNA and RNA, including complementary base-pairing rules.
The central dogma of molecular biology (how genetic information flows from DNA to RNA to proteins).
Basic mechanisms of bacterial immunity against viral infections (bacteriophages).
Standard DNA repair pathways in eukaryotic cells, specifically Non-Homologous End Joining (NHEJ) and Homology-Directed Repair (HDR).
Advanced genome editing technologies, such as base editing and prime editing, which do not require double-stranded DNA breaks.
Delivery methodologies for CRISPR therapeutics, including lipid nanoparticles (LNPs) and viral vectors (AAVs).
The bioethics and regulatory landscape surrounding somatic vs. germline genetic modification in humans.
Applications of CRISPR beyond therapeutics, such as gene drives for pest control, crop engineering for climate resilience, and diagnostic tools like SHERLOCK.
21.8K views376likes1:05:25@cmuOriginal Release: 2018-02-01

CRISPR-Cas9 is a revolutionary gene editing technology derived from bacterial adaptive immune systems, where the Cas9 enzyme, guided by RNA, can precisely cut DNA at specific locations, enabling scientists to edit genomes with unprecedented speed and accuracy; this technology, first described by Jennifer Doudna and colleagues in 2012, has transformed genetic research and holds promise for treating genetic diseases while raising important ethical considerations about its applications.